Tornai Dávid

1.

Papp, M., Tornai, D.: Immunoglobulin A antibodies: prognostic tools with unknown mechanism in primary sclerosing cholangitis.
Pol. Arch. Intern. Med. 135 (1), 1-2, (article identifier: 16938), 2025.

doi DEA WoS Scopus

2.

Fehér, K. E., Tornai, D., Vitális, Z., Dávida, L., Sipeki, N., Papp, M.: Non-pancreatic hyperlipasemia: a puzzling clinical entity.
World J. Gastroenterol. 30 (19), 2538-2552, 2024.

doi DEA WoS Scopus

Journal metrics:

Q1 Gastroenterology (2023)

Q1 Medicine (miscellaneous) (2023)

3.

Torp, N., Israelsen, M., Coenraad, M., Papp, M., Shawcross, D. L., Korenjak, M., Angeli, P., Laleman, W., Juanola, A., Ginès, P., Trebica, J., Krag, A., MINCROB-PREDICT Consortium: Personalised human albumin in patients with cirrhosis and ascites: design and rationale for the ALB-TRIAL - a study protocol of a randomised clinical biomarker validation trial.
BMJ Open. 14 (2), 1-8, (article identifier: 079309), 2024.

DEA WoS Scopus

4.

Tornai, D., Mitchell, M., McClain, C., Dasarathy, S., McCullough, A., Radaeva, S., Kroll-Desrosiers, A., Lee, J., Barton, B., Szabó, G.: A novel score of IL-13 and age predicts 90-day mortality in severe alcohol-associated hepatitis: a multicenter plasma biomarker analysis.
Hepatol. Commun. 7 (12), 1-13, (article identifier: 0296), 2023.

doi DEA WoS Scopus

Journal metrics:

Q1 Hepatology

5.

Sciascia, S., Bizzaro, N., Meroni, P. L., Bogdanos, D. P., Borghi, M. O., Bossuyt, X., Grossi, C., Tornai, D., Papp, M., Shoenfeld, Y., Ielo, D., Fritzler, M. J.: Autoantibodies testing in autoimmunity: Diagnostic, prognostic and classification value.
Autoimmun. Rev. 22 (7), 1-9, (article identifier: 103356), 2023.

doi DEA WoS Scopus

Journal metrics:

Q1 Immunology

D1 Immunology and Allergy

6.

Cho, Y., Bukong, T. N., Tornai, D., Babuta, M., Vlachos, I. S., Kanata, E., Catalano, D., Szabó, G.: Neutrophil extracellular traps contribute to liver damage and increase defective low-density neutrophils in alcoholic hepatitis.
J. Hepatol. 78 (1), 28-44, 2023.

doi DEA WoS Scopus

Journal metrics:

D1 Hepatology

7.

Walmsley, M., Tornai, D., Cazzagon, N., Leburgue, A., Mrzljak, A., Lenzen, H., Carbone, M., Madaleno, J., Lleo, A., Junge, N., Schramm, C., Bergquist, A.: Patient-reported quality of care in primary sclerosing cholangitis.
Liver Int. 43 (8), 1654-1662, 2023.

doi DEA WoS Scopus

Journal metrics:

Q1 Hepatology

8.

Janka, T., Tornai, D., Papp, M., Vitális, Z.: The Value of Neutrophil-to-Lymphocyte Ratio to Identify Bacterial Infection and Predict Short-Term Mortality in Patients with Acutely Decompensated Cirrhosis.
Diagnostics. 13 (18), 1-14, (article identifier: 2954), 2023.

doi DEA WoS Scopus

Journal metrics:

Q2 Clinical Biochemistry

9.

Vitális, Z., Balogh, B., Tornai, D., Papp, M.: A máj-cirrhosis akut dekompenzációja.
Orvostovábbk. szle. 29 (3), 57-71, 2022.

DEA

10.

Szabó, G., Mitchell, M., McClain, C., Dasarathy, S., Barton, B., McCullough, A., Nagy, L. E., Kroll-Desrosiers, A., Tornai, D., Min, H. A., Radaeva, S., Holbein, M. E. B., Casey, L., Cuthbert, J.: IL-1 receptor antagonist plus pentoxifylline and zinc for severe alcohol-associated hepatitis.
Hepatology. 76 (4), 1058-1068, 2022.

doi DEA WoS Scopus

Journal metrics:

D1 Hepatology

D1 Medicine (miscellaneous)

11.

Szabó, G., Mitchell, M., McClain, C., Dasarathy, S., Barton, B., McCullough, A., Nagy, L. E., Kroll-Desrosiers, A., Tornai, D., Min, H. A., Radaeva, S., Casey, L., Cuthbert, J.: Response from Authors of HEP-21-2131.R1.
Hepatology. 76 (5), E114-E115, 2022.

doi DEA WoS Scopus

12.

Tornai, D., Vén, P. L., Lakatos, P., Papp, M.: Serological biomarkers for management of primary sclerosing cholangitis.
World J. Gastroenterol. 28 (21), 2291-2301, 2022.

DEA WoS Scopus

Journal metrics:

Q1 Gastroenterology

Q1 Medicine (miscellaneous)

13.

Tornai, D., Antal-Szalmás, P., Tornai, T. I., Papp, M., Tornai, I., Sipeki, N., Janka, T., Balogh, B., Vitális, Z.: Abnormal ferritin levels predict development of poor outcomes in cirrhotic outpatients: a cohort study.
BMC Gastroenterol. 21 (1), 1-13, 2021.

doi DEA

Journal metrics:

Q2 Gastroenterology

Q2 Medicine (miscellaneous)

14.

Tornai, D., Papp, M.: Editorial: serologic antibodies in primary sclerosing cholangitis - a tell-tale sign of compromised gut-liver immunity?.
Aliment. Pharmacol. Ther. 53 (2), 350-351, 2021.

doi DEA WoS Scopus

Journal metrics:

D1 Gastroenterology

D1 Hepatology

D1 Pharmacology (medical)

15.

Tornai, D., Vitális, Z., Jónás, A., Janka, T., Földi, I., Tornai, T. I., Sipeki, N., Csillag, A., Balogh, B., Sümegi, A., Földesi, R., Papp, M., Antal-Szalmás, P.: Increased sTREM-1 levels identify cirrhotic patients with bacterial infection and predict their 90-day mortality.
Clin. Res. Hepatol. Gastroenterol. 45 (5), 1-12, 2021.

doi DEA

Journal metrics:

Q3 Gastroenterology

Q3 Hepatology

16.

Janka, T., Tornai, T. I., Borbély, B., Tornai, D., Altorjay, I., Papp, M., Vitális, Z.: Deleterious effect of proton pump inhibitors on the disease course of cirrhosis.
Eur. J. Gastroenterol. Hepatol. 32 (2), 257-264, 2020.

doi DEA

Journal metrics:

Q2 Gastroenterology

Q3 Hepatology

17.

Tornai, D., Szabó, G.: Emerging medical therapies for severe alcoholic hepatitis.
Clin Mol Hepatol. 26 (4), 686-696, 2020.

doi DEA

Journal metrics:

Q2 Hepatology

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

18.

Csillag, A., Vitális, Z., Tornai, T. I., Tornai, I., Tornai, D., Balogh, B., Antal-Szalmás, P., Papp, M.: Filamentosus-actin related molecules: are they serologic hallmark of overwhelming damage-associated molecular patterns (DAMPs) in acute decompensation?.
In: "PROCEEDINGS OF THE EFOP-3.6.2- 16-2017-00006 (LIVE LONGER) PROJECT". Ed.: Rakonczay Zoltán, Kiss Lóránd, Szegedi Tudományegyetem, Szeged, 63, 2020. ISBN: 9789633067642

DEA

19.

Balogh, B., Vitális, Z., Tornai, T. I., Tornai, I., Tornai, D., Csillag, A., Antal-Szalmás, P., Papp, M.: Gut barrier failure: a piece in the puzzle of acute-on chronic liver failure syndrome development?.
In: Proceedings of the EFOP-3.6.2-16-2017-00006 (LIVE LONGER) project /Ed. Rakonczay Zoltán, Kiss Lóránd, University of Szeged, Szeged, 62, 2020.

DEA

20.

Lowe, P., Cho, Y., Tornai, D., Coban, S., Catalano, D., Szabó, G.: Inhibition of the Inflammasome Signaling Cascade Reduces Alcohol Consumption in Female But Not Male Mice.
Alcohol. Clin. Exp. Res. 44 (2), 567-578, 2020.

doi DEA

Journal metrics:

Q1 Medicine (miscellaneous)

Q1 Psychiatry and Mental Health

D1 Toxicology

21.

Mezei, Z. A., Tornai, D., Földesi, R., Madar, L., Sümegi, A., Papp, M., Antal-Szalmás, P.: A DNA pool of FLT3-ITD positive DNA samples can be used efficiently for analytical evaluation of NGS-based FLT3-ITD quantitation: testing several different ITD sequences and rates, simultaneously.
J. Biotechnol. 303, 25-29, 2019.

doi DEA WoS Scopus

Journal metrics:

Q1 Applied Microbiology and Biotechnology

Q2 Bioengineering

Q1 Biotechnology

Q1 Medicine (miscellaneous)

22.

Tornai, D., Mitchell, M. C., McClain, C., Dasarathy, S., McCullough, A., Radaeva, S., Kroll-Desrosiers, A., Barton, B., Szabó, G.: A novel composite score of biomarkers and age predicts mortality in severe alcoholic hepatitis patients.
Hepatology. 70 (Suppl.), 835A, 2019.

doi DEA

23.

Saha, B., Tornai, D., Kodys, K., Adejumo, A., Lowe, P., McClain, C., Mitchell, M., McCullough, A., Dasarathy, S., Kroll-Desrosiers, A., Barton, B., Radaeva, S., Szabó, G.: Biomarkers of Macrophage Activation and Immune Danger Signals Predict Clinical Outcomes in Alcoholic Hepatitis.
Hepatology. 70 (4), 1134-1149, 2019.

doi DEA

Journal metrics:

D1 Hepatology

D1 Medicine (miscellaneous)

24.

Tornai, D., Furi, I., Shen, Z. T., Sigalov, A. B., Coban, S., Szabó, G.: Inhibition of Triggering Receptor Expressed on Myeloid Cells 1 Ameliorates Inflammation and Macrophage and Neutrophil Activation in Alcoholic Liver Disease in Mice.
Hepatol. Commun. 3 (1), 99-115, 2019.

doi DEA

25.

Dinya, T., Tornai, T. I., Vitális, Z., Tornai, I., Balogh, B., Tornai, D., Antal-Szalmás, P., Sümegi, A., Andrikovics, H., Bors, A., Tordai, A., Papp, M.: Functional polymorphisms of innate immunity receptors are not risk factors for the non-SBP type bacterial infections in cirrhosis.
Liver Int. 38 (7), 1242-1252, 2018.

doi DEA

Journal metrics:

Q1 Hepatology

Publication list